Karyopharm Therapeutics



Ebitda Zmiana Data
AbbVie USD 6.92B 258M 2024-12
Abbott USD 2.18B 486M 2025-03
Amgen USD 3.75B 42M 2025-03
AstraZeneca USD 5.08B 182M 2025-03
Bristol-Myers Squibb USD 4.9B 16M 2025-03
Eli Lilly USD 4.16B 2B 2025-03
GlaxoSmithKline GBP 3.14B 1.06B 2025-03
Incyte USD 222.66M 97.54M 2025-03
J&J USD 7.88B 1.76B 2025-03
MacroGenics USD -50784000 106.81M 2024-12
Merck USD 7.74B 625M 2025-03
Novartis USD 5.19B 319M 2024-12
Novartis USD 6.82B 1.31B 2024-12
Pfizer USD 6.21B 1.5B 2025-03
Regeneron Pharmaceuticals USD 730.9M 324.8M 2025-03
Roche Holding CHF 12.68B 2.36B 2024-06
Takeda JPY 128.14B 126.45B 2025-03
Tectonic Therapeutic USD -13483000 5.73M 2024-12
TG Therapeutics USD 29.96M 12.91M 2024-12
Ultragenyx Pharmaceutical USD -113199000 10.03M 2024-12
Xencor USD -36907000 44.05M 2025-03



Karyopharm Therapeutics - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Jul 2025.